Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) – 2019 to 2025

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: March 23, 2020
Clear
SKU: GMS-2066 Category:

The global biobanks market is expected to grow at a CAGR of 8.78% during the forecast period 2020-2025. This is primarily attributable to the increasing number of biobanks and the increasing number of biosamples around the world, resulting in high demand for equipment.

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 1

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 2

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 3

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 4

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 5

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 6

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 7

Biobanking Market by Sample Type (Cell Lines, Human Tissues, Blood Products, Nucleic Acids), Product and Service (Consumables, Services, Equipment, Software), Application (Clinical Research, Life Science, Regenerative Medicine) - 2019 to 2025 8

1 Global Biobanking Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Biobanking Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Biobanking Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Biobanking Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Biobanking Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Biobanking Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Biobanking Market – By Product & Service (Market Size – & million/billion)
8.1 Equipment
8.2 Consumables
8.3 Services
8.4 Software

9 Global Biobanking Market – By Sample Type
9.1 Blood Products
9.2 Human Tissues
9.3 Nucleic Acids
9.4 Biological Fluids
9.5 Human Waste Products

10 Global Biobanking Market – By Application
10.1 Regenerative Medicine
10.2 Life Science Research
10.3 Clinical Research

11 Global Biobanking Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Biobanking Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Biobanking Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific Inc.
13.3 Panasonic Healthcare Holdings Co., Ltd.
13.4 Becton, Dickinson and Company
13.5 Chart Industries, Inc.
13.6 Hamilton Company
13.7 Qiagen N.V.
13.8 Merck KGaA
13.9 VWR Corporation
13.10 Tecan Trading AG
13.11 Brooks Automation, Inc.
13.12 Company 11 & more

14 Global Biobanking Market – Appendix
14.1 Sources
14.2 Abbreviations